Todd Davis is Chief Executive Officer of Ligand Pharmaceuticals Inc (LGND). The company reported total compensation of $11,472,095 for fiscal year 2025.
| Salary | $724,500 |
|---|---|
| Bonus | $0 |
| Stock awards | $5,520,493 |
| Option awards | $4,441,120 |
| Non-equity incentive plan | $764,400 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $21,582 |
| Total | $11,472,095 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Ligand Pharmaceuticals Inc filed April 21, 2026, accession 0000886163-26-000021.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $724,500 | $0 | $5,520,493 | $4,441,120 | $764,400 | $0 | $21,582 | $11,472,095 |
| FY2024 | Chief Executive Officer | $695,834 | $0 | $6,429,536 | $5,142,650 | $637,000 | $0 | $9,960 | $12,914,980 |
| FY2023 | Chief Executive Officer | $650,007 | $0 | $3,378,456 | $1,788,095 | $390,000 | $0 | $9,960 | $6,216,518 |
Totals as disclosed in each year's own compensation disclosure for Ligand Pharmaceuticals Inc.
| Peer-group chief executive median | $8,429,887 |
|---|---|
| Difference from that median | $3,042,208 |
| Percentile within the disclosed peer group | 73rd |
| Peers with a disclosed figure | 15 |
Medians and percentiles are computed across the peer group Ligand Pharmaceuticals Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Todd Davis this page | Chief Executive Officer | $11,472,095 |
| Octavio Espinoza | Chief Financial Officer | $4,382,148 |
| Andrew Reardon | Chief Legal Officer and Secretary | $3,747,282 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Ligand Pharmaceuticals Inc compensation brief.
Todd Davis's compensation sits inside Ligand Pharmaceuticals Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.